v3.26.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jan. 30, 2026
Jul. 29, 2024
Sep. 30, 2026
Jun. 30, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Product Information [Line Items]                  
Cash and cash equivalents     $ 1,941       $ 1,941   $ 18,270
Working capital             $ 2,973    
Net increase in cash                 90,930
Number of shares issued, value     202 $ 829   $ 63      
Number of shares converted             72,658    
Net proceeds from conversion of preferred stock             $ 7,330  
Inventory reserves     740       740   300
Amortization expense     38   $ 0   45 0  
Impairment loss             0 0  
Customer deposits     242   314   242 314 121
Revenue     12,174   15,967   35,037 45,571  
Grant income     408       531    
Warranty obilgation outstanding     901       901   867
Warranty expense     95   $ 132   293 $ 403  
Income tax reconciliation pretax loss             16,550    
Prepaid income taxes     $ 359       359   $ 353
Amount of goodwill expected to be deductible for income tax             $ 372    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage             23.00%   31.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage             12.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer C [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage             10.00%    
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage     22.00%   35.00%   22.00% 29.00%  
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage             33.00%   36.00%
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage             10.00%   16.00%
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Vendor C [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage                 12.00%
Total Purchases [Member] | Supplier Concentration Risk [Member] | Vendor A [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage     19.00%   18.00%   12.00% 17.00%  
Total Purchases [Member] | Supplier Concentration Risk [Member] | Vendor B [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage     12.00%            
Total Purchases [Member] | Supplier Concentration Risk [Member] | Vendor F [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage         14.00%        
Total Purchases [Member] | Supplier Concentration Risk [Member] | Vendor E [Member]                  
Product Information [Line Items]                  
Concentration risk, percentage             10.00% 10.00%  
Minimum [Member]                  
Product Information [Line Items]                  
Payment term for distributors and OEMs             30 days    
Term of product warranty provided             5 years    
Maximum [Member]                  
Product Information [Line Items]                  
Payment term for distributors and OEMs             90 days    
Term of product warranty provided             10 years    
Series A Convertible Preferred Stock [Member]                  
Product Information [Line Items]                  
Net proceeds from conversion of preferred stock             $ 1,031    
Equity Distribution Agreement [Member]                  
Product Information [Line Items]                  
Number of shares issued, value $ 50,000                
License Agreement [Member]                  
Product Information [Line Items]                  
Licensing fee   $ 5,000              
Estimated useful life   5 years              
Revenue     $ 250       750    
Deferred revenue     $ 2,833       $ 2,833   $ 3,583